Xpeng Q4 Earnings Preview: Chinese EV Landscape Turned Unfavorable

Xpeng reported record Q3 2025 deliveries and revenue but missed consensus and used margin-eroding promotions to clear inventory. Slowing domestic demand and intensifying pricing wars, coupled with persistent unprofitability, make XPEV's premium P/S of 1.93x hard to justify despite its innovation and international expansion.

Analysis

Margin compression at a loss-making OEM has outsized ripple effects down the value chain: suppliers with fixed-cost battery-cell factories will see order distortions (lumpy demand + renegotiated pricing) that can erode OEM-tier margins further and force suppliers into lower-margin aftermarket or energy-storage channels within 6–18 months. Independent dealers and financing arms will bear residual inventory and lease residual-risk, increasing credit losses and forcing higher incentive programs that mechanically depress industry ASPs and used-car residuals.

Near-term catalysts are concentrated and binary: promotional cadence and inventory metrics will reprice expectations within 0–3 months, while structural demand shifts and product-cycle refreshes play out over 6–24 months. Tail risks include an escalation in cross-subsidized pricing from deep-pocket incumbents or policy shifts (tariff/subsidy changes) that could accelerate consolidation; conversely, durable margin relief would require 10–15% structural cost takeouts or new high-margin services scaled to meaningful attachment rates (12–24 months).

Competitively, mid-cap EV makers that can defend ASPs or monetize software will win share from players that cannot sustain cash burn; this creates a bifurcation where surviving scale players capture supplier leverage and bi-directional pricing power. The market may be under-pricing the optionality from software/recurring revenue and over-pricing continued top-line growth — the former could re-rate the stock if executed, but execution risk is high and timelines long (2+ years).

Key Decisions for Investors

• Short XPEV equity (size 1-2% NAV): target 35–50% downside over 6–12 months; initial stop-loss at 20% adverse move. Rationale: asymmetric downside as market re-prices growth/valuation gap if margin normalization fails.
• Pair trade — short XPEV / long BYDDF or BYDDY (1:1 notional) over 6–12 months: hedges macro China beta and isolates execution/ASP compression differential. Expect relative performance skew of 25–40% if pricing wars persist; close if spread narrows to <10% of entry or within 3 months if macro shock hits both.
• Buy a defined-risk put spread on XPEV (9–12 month expiry): buy ATM puts and sell far-OTM puts to fund ~60–70% of premium. Structure to deliver ~3:1 downside payoff vs premium if equity drops 30–40%, limits capital at risk while retaining significant downside exposure.
• Event hedge: purchase 4–6 week ATM puts ahead of next quarterly results (size <0.5% NAV) to protect against near-term promotional/earnings surprises. Close into the print or roll to longer-dated protection if guidance implies durable margin fixes.